(en) Dejesus-Hernandez, M., et al.,, « Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. », Neuron, vol. 72, no 2, , p. 245–56 (PMID21944778, DOI10.1016/j.neuron.2011.09.011, lire en ligne)
(en) Limone, F., Mordes, D.A., Couto, A. et al., « Single-nucleus sequencing reveals enriched expression of genetic risk factors in extratelencephalic neurons sensitive to degeneration in ALS », Nature Aging, (DOI10.1038/s43587-024-00640-0).
(en) Albert C. Ludolph, Johannes Brettschneider et Jochen H. Weishaupt, « Amyotrophic lateral sclerosis: », Current Opinion in Neurology, vol. 25, no 5, , p. 530–535 (ISSN1350-7540, DOI10.1097/WCO.0b013e328356d328, lire en ligne, consulté le )
Michele Longoni Calió, Elisandra Henriques, Amanda Siena et Clélia Rejane Antonio Bertoncini, « Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment », Frontiers in Neuroscience, vol. 14, , p. 679 (ISSN1662-453X, PMID32760239, PMCIDPMC7373761, DOI10.3389/fnins.2020.00679, lire en ligne, consulté le )
Simon J. Guillot, Christina Lang, Marie Simonot et Daniel Beckett, « Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse models », Science Translational Medicine, vol. 17, no 783, , eadm7580 (DOI10.1126/scitranslmed.adm7580, lire en ligne, consulté le )
(en) Deng et al., Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia, dans Nature (2011) DOI10.1038/nature10353
(en) Dejesus-Hernandez, M., et al.,, « Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. », Neuron, vol. 72, no 2, , p. 245–56 (PMID21944778, DOI10.1016/j.neuron.2011.09.011, lire en ligne)
(en) Majounie E., et al., « Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. », Lancet Neurology, vol. 11, no 4, , p. 323–330 (DOI10.1016/S1474-4422(12)70043-1)
(en) Writing Group et Edaravone (MCI-186) ALS 19 Study Group, « Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial », The Lancet. Neurology, vol. 16, no 7, , p. 505–512 (ISSN1474-4465, PMID28522181, DOI10.1016/S1474-4422(17)30115-1, lire en ligne, consulté le )
dtic.mil
(en) Homer, R. D. ; Kamins, K. G. ; Feussner, J. R. ; Grambow, S. C. ; Hoff-Lindquist, J.(2002) « Occurrence of Amyotropic Lateral Sclerosis Among Gulf War Veterans » ; Descriptive Note : Rept. for 2 Aug 1990-31 Jul 1991 Corporate Author : Naval Health research center San Diego CA
Michele Longoni Calió, Elisandra Henriques, Amanda Siena et Clélia Rejane Antonio Bertoncini, « Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment », Frontiers in Neuroscience, vol. 14, , p. 679 (ISSN1662-453X, PMID32760239, PMCIDPMC7373761, DOI10.3389/fnins.2020.00679, lire en ligne, consulté le )
(en) Zhisui Li, Private Life Of Chairman Mao : The Memoirs of Mao's Personal Physician (illustrated, reprint ed.), Random House, , 720 p. (ISBN978-1-4070-5922-8, lire en ligne), p. 581
A. Chiò, G. Logroscino, O. Hardiman, R. Swingler, D. Mitchell, E. Beghi et B.G. Traynor, « Prognostic factors in ALS: A critical review », Amyotrophic Lateral Sclerosis, vol. 10, nos 5-6, , p. 310-323 (résumé).
(en) Albert C. Ludolph, Johannes Brettschneider et Jochen H. Weishaupt, « Amyotrophic lateral sclerosis: », Current Opinion in Neurology, vol. 25, no 5, , p. 530–535 (ISSN1350-7540, DOI10.1097/WCO.0b013e328356d328, lire en ligne, consulté le )
Michele Longoni Calió, Elisandra Henriques, Amanda Siena et Clélia Rejane Antonio Bertoncini, « Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment », Frontiers in Neuroscience, vol. 14, , p. 679 (ISSN1662-453X, PMID32760239, PMCIDPMC7373761, DOI10.3389/fnins.2020.00679, lire en ligne, consulté le )
(en) Writing Group et Edaravone (MCI-186) ALS 19 Study Group, « Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial », The Lancet. Neurology, vol. 16, no 7, , p. 505–512 (ISSN1474-4465, PMID28522181, DOI10.1016/S1474-4422(17)30115-1, lire en ligne, consulté le )
(en) Albert C. Ludolph, Johannes Brettschneider et Jochen H. Weishaupt, « Amyotrophic lateral sclerosis: », Current Opinion in Neurology, vol. 25, no 5, , p. 530–535 (ISSN1350-7540, DOI10.1097/WCO.0b013e328356d328, lire en ligne, consulté le )
medhyg.ch
titan.medhyg.ch
Jelena Grujic, Martial Coutaz et Jérôme Morisod, « La sclérose latérale amyotrophique atteint aussi le quatrième âge (Amyotrophic lateral sclerosis also threatens the octogenarian) », Rev med suisse, vol. 4, no 159, , p. 1353-1357 (PMID18592728, lire en ligne, consulté le )
(en) MA van Es, JH Veldink, CG Sariset al., « Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis », Nat Genet, no 41, , p. 1083-1087 (lire en ligne)
(en) S Cronin, O Hardiman et BJ Traynor, « Ethnic variation in the incidence of ALS: a systematic review », Neurology, no 68, , p. 1002-1007 (lire en ligne)
Jelena Grujic, Martial Coutaz et Jérôme Morisod, « La sclérose latérale amyotrophique atteint aussi le quatrième âge (Amyotrophic lateral sclerosis also threatens the octogenarian) », Rev med suisse, vol. 4, no 159, , p. 1353-1357 (PMID18592728, lire en ligne, consulté le )
Michele Longoni Calió, Elisandra Henriques, Amanda Siena et Clélia Rejane Antonio Bertoncini, « Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment », Frontiers in Neuroscience, vol. 14, , p. 679 (ISSN1662-453X, PMID32760239, PMCIDPMC7373761, DOI10.3389/fnins.2020.00679, lire en ligne, consulté le )
(en) F Bonvicini, N Marcello, J Mandrioli, V Pietrini et M Vinceti, « Exposure to pesticides and risk of amyotrophic lateral sclerosis: a population-based case-control study », Ann Ist Super Sanita, vol. 46, no 3, , p. 284-287 (PMID20847462)
(en) AM Malek, A Barchowsky, R Bowser, A Youk et EO Talbott, « Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: A meta-analysis of epidemiological studies: Pesticide exposure as a risk factor for ALS », Environ Res., no 117, , p. 112-119 (PMID22819005)
(en) M Vinceti, I Bottecchi, A Fan, Y Finkelstein et J Mandrioli, « Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? », Rev Environ Health, vol. 27, no 1, , p. 19-41 (PMID22755265)
(en) F Kamel, DM Umbach, RS Bedlack, M Richards, M Watsonet al., « Pesticide exposure and amyotrophic lateral sclerosis », Neurotoxicology, vol. 33, no 3, , p. 457-462 (PMID22521219)
(en) CA Harwood, CJ McDermott et PJ Shaw, « Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence », Amyotroph Lateral Scler, no 10, , p. 191-204 (PMID19263258)
(en) M Gotkine, Y Friedlander et Hochner, « Triathletes are over-represented in a population of patients with ALS », Amyotroph Lateral Sclerosis and Frontotemporal Degeneration, , p. 1-3 (PMID25007701)
(en) Dejesus-Hernandez, M., et al.,, « Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. », Neuron, vol. 72, no 2, , p. 245–56 (PMID21944778, DOI10.1016/j.neuron.2011.09.011, lire en ligne)
(en) Writing Group et Edaravone (MCI-186) ALS 19 Study Group, « Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial », The Lancet. Neurology, vol. 16, no 7, , p. 505–512 (ISSN1474-4465, PMID28522181, DOI10.1016/S1474-4422(17)30115-1, lire en ligne, consulté le )
(en) E. Beghi, G. Logroscino, A. Chiò, O. Hardiman, A. Millul, D. Mitchell, R. Swingler et B.J. Traynor, « Amyotrophic lateral sclerosis, physical exercise, trauma and sports: Results of a population-based pilot case-control study », Amyotrophic Lateral Sclerosis, vol. 11, no 3, , p. 289-292 (lire en ligne [PDF]).
Simon J. Guillot, Christina Lang, Marie Simonot et Daniel Beckett, « Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse models », Science Translational Medicine, vol. 17, no 783, , eadm7580 (DOI10.1126/scitranslmed.adm7580, lire en ligne, consulté le )
(en) V Gallo, HB Bueno-De-Mesquita, R Vermeulenet al., « Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort », Ann Neurol, no 65, , p. 378-385 (lire en ligne)
